Out-licensing: Diagnostic & Immune Related Disorders

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 1..10 of 18 - per page Next page
Order by

Cripto-1 Represents a Biomarker for Chronic Inflammatory Diseases

Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More

Antibody APA1/1 as a marker for TCR-engaged T cells

This antibody is specific for the TCR CD3 epsilon chain and can also be used to identify this subunit in immunoprecipitation and immunoblotting applications More

Immunogenic T Cell Targets in Autoimmune Hepatitis and Methods of Use

New methods of diagnosing and monitoring the progression or response to therapy of subjects with autoimmune hepatitis More

Methods and Compositions for Treating FUS1 Related Disorders

Methods, systems and transgenic animals useful for screening, diagnosing and treating FUS1 related disorders More

A Novel and Efficient Technology for Targeted Delivery of siRNA

Novel compositions and methods for delivering inhibitory oligonucleotides to cells in a targeted and efficient manner have been developed. More

BIO-015 - DIABETES - New Biomarker Panel for the Detection and Diagnosis of Type 1 Diabetes

This invention concerns the development of a new biomarker panel for the detection and diagnosis of Type 1 diabetes. More

BIO-013 - RHEUMATOID ARTHRITIS - Novel Autoantigenic Peptides for Use in the Diagnosis and Treatment of Rheumatoid Arthritis

This invention concerns the discovery of novel autoantigenic peptides useful for the diagnosis and treatment of rheumatoid arthritis. More

Modulators of Nuclear Hormone Receptor Activity: Novel Compounds, Diverse Applications for Infectious Diseases, Including Anthrax (B. anthracis)

Novel agents that can interfere with the action of nuclear hormone receptors More

Method for Predicting Treatments' Success Based On Genetic Data

An automated algorithm for prognosis of treatment success by gene expression profile (GEP) of the patient More

Organic and Organometallic Synthesis Laboratory

The laboratory is active in the field of synthesizing biologically active small molecules. The molecules can be heterocyclic and may also contain boron and phosphorus More

Displaying 1..10 of 18 - per page Next page
Order by

Your selection

Industry sector: Diagnostic del
Therapeutic target: Immune related disorders del

Browse By

Industry sector: Antibody-based diagnostics; Biomarker-based diagnostics; CAT; Genetic diagnostics; Imaging; MRI; Nuclear medicine; Other; Self-test systems; Supplies; Test systems; Ultrasound; X-ray
Therapeutic target: Adoptive immunotherapy; Amyloidosis; Autoimmune disease (non-specific); Chronic fatigue syndrome; Chronic granulomatous disease; Chronic immunosuppression; Gout; Graft versus host disease; HIV/AIDS; Immune disorder (non-specific); Immune thrombocytopenic purpura; Immunomodulation; Immunostimulation; Immunosuppression; Lupus erythematosis; Myalgic encephalomyelitis; Myasthenia gravis; Neoplastic disease; Organ transplant rejection; Rheumatoid arthritis; Servere combined immunodeficency; Sjogren's syndrome; Systemic sclerosis; Transplant rejection; Xenotransplantation
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us